Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-023993
Filing Date
2024-06-14
Accepted
2024-06-14 20:46:01
Documents
1
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3364
  Complete submission text file 0001493152-24-023993.txt   4833
Mailing Address 498 SEVENTH AVE NEW YORK NY 10018
Business Address
DIAMOND STUART (Reporting) CIK: 0001259438 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41463 | Film No.: 241046783

Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Issuer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)